{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:52:56Z","timestamp":1778338376672,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.mehy.2019.05.013","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T19:46:31Z","timestamp":1557776791000},"page":"91-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["CRISPR\/Cas 9 system for the treatment of dilated cardiomyopathy: A hypothesis related to function of a MAP kinase"],"prefix":"10.1016","volume":"128","author":[{"given":"J\u00e9ssica","family":"Olivaes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn Hern\u00e1n","family":"Bonamino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa Medeiros","family":"Markoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2019.05.013_b0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/fca.13.66","article-title":"Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies","volume":"9","author":"Lipshultz","year":"2013","journal-title":"Future Cardiol"},{"key":"10.1016\/j.mehy.2019.05.013_b0010","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1016\/j.jacc.2016.08.079","article-title":"Clinical and mechanistic insights into the genetics of cardiomyopathy","volume":"68","author":"Burke","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2019.05.013_b0015","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2019.05.013_b0020","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/CIRCULATIONAHA.110.011999","article-title":"Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy","volume":"126","author":"Pietra","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2019.05.013_b0025","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.jacc.2003.10.021","article-title":"Mutations in cypher\/ZASP in patients with dilated cardiomyophaty and left ventricular non-compactation","volume":"42","author":"Vatta","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2019.05.013_b0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13073-017-0410-8","article-title":"Genetics and genomics of dilated cardiomyopathy and systolic heart failure","volume":"9","author":"Tayal","year":"2017","journal-title":"Genome Med"},{"key":"10.1016\/j.mehy.2019.05.013_b0035","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0140-6736(02)09879-3","article-title":"Dilated cardyomyophaty: a genetically heterogeneous disease","volume":"360","author":"Shaw","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2019.05.013_b0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0031-3955(05)70119-X","article-title":"Pediatric myocardial disease","volume":"46","author":"Towbin","year":"1999","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.mehy.2019.05.013_b0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/CIA.S155145","article-title":"Genome-editing applications of CRISPR\u2013Cas9 to promote in vitro studies of Alzheimer\u2019s disease","volume":"13","author":"Giau","year":"2018","journal-title":"Clin Interv Aging"},{"issue":"6","key":"10.1016\/j.mehy.2019.05.013_b0050","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/ATVBAHA.116.304790","article-title":"A CRISPR path to engineering new genetic mouse models for cardiovascular research","volume":"36","author":"Miano","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.mehy.2019.05.013_b0055","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.18632\/oncotarget.14072","article-title":"Targeted delivery of CRISPR\/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome","volume":"8","author":"Zhen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.mehy.2019.05.013_b0060","first-page":"81","article-title":"The CRISPR\/Cas9 system and the possibility of genomic edition for cardiology","volume":"108","author":"Arend","year":"2017","journal-title":"Arq Bra Cardiol"},{"key":"10.1016\/j.mehy.2019.05.013_b0065","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3390\/v4102291","article-title":"Function and regulation of clustered regularly interspaced short palindromic repeats (CRISPR)\/CRISPR associated (Cas) systems","volume":"4","author":"Richter","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.mehy.2019.05.013_b0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ymthe.2016.10.014","article-title":"CRISPR\/Cas9-induced (CTG\u22c5CAG)n repeat instability in the myotonic dystrophy type 1 locus: implications for therapeutic genome editing","volume":"25","author":"Van Agtmaal","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.mehy.2019.05.013_b0075","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and application of CRISPR-Cas9 for Genome Engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2019.05.013_b0080","unstructured":"Addgene. CRISPR 101: A desktop resource. 1st edition. Jan 2016."},{"key":"10.1016\/j.mehy.2019.05.013_b0085","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.280.5364.750","article-title":"Actin mutations in dilated cardiomyopathy, a heritable form of heart failure","volume":"280","author":"Olson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.mehy.2019.05.013_b0090","article-title":"Calreticulin induces dilated cardiomyopathy","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2019.05.013_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000647","article-title":"Tnni3k modifies disease progression in murine models of cardiomyopathy","volume":"5","author":"Wheeler","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.mehy.2019.05.013_b0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1152\/physiolgenomics.00122.2001","article-title":"Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure","volume":"10","author":"Hwang","year":"2002","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.mehy.2019.05.013_b0105","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.12659\/MSM.894630","article-title":"TNNT2 Gene polymorphisms are associated with susceptibility to idiopathic dilated cardiomyopathy in Kazak and Han Chinese","volume":"21","author":"Li","year":"2015","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.mehy.2019.05.013_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2016.01.006","article-title":"TNNT1, TNNT2, and TNNT3: isoform genes, regulation, and structure-function relationships","volume":"582","author":"Wei","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.mehy.2019.05.013_b0115","doi-asserted-by":"crossref","first-page":"207ra141","DOI":"10.1126\/scitranslmed.3006479","article-title":"Inhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart","volume":"5","author":"Vagnozzi","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.mehy.2019.05.013_b0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00109-003-0427-x","article-title":"Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I","volume":"81","author":"Zhao","year":"2003","journal-title":"J Mol Med"},{"key":"10.1016\/j.mehy.2019.05.013_b0125","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/stem.2070","article-title":"Concise review: cardiac disease modeling using induced pluripotent stem cells","volume":"33","author":"Yang","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.mehy.2019.05.013_b0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fbioe.2016.00099","article-title":"An efficient electroporation protocol for the genetic modification of mammalian cells","volume":"4","author":"Chicaybam","year":"2017","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.mehy.2019.05.013_b0135","doi-asserted-by":"crossref","first-page":"8960236","DOI":"10.1155\/2017\/8960236","article-title":"The impact of CRISPR\/Cas9 technology on cardiac research: from disease modelling to therapeutic approaches","volume":"2017","author":"Motta","year":"2017","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.mehy.2019.05.013_b0140","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/ncomms7244","article-title":"Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause duchenne muscular dystrophy","volume":"6","author":"Ousterout","year":"2015","journal-title":"Nature Comm"},{"key":"10.1016\/j.mehy.2019.05.013_b0145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13238-015-0153-5","article-title":"CRISPR\/Cas9-mediated geneediting in human tripronuclear zygotes","volume":"6","author":"Liang","year":"2015","journal-title":"Protein Cell"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719301926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719301926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T16:41:38Z","timestamp":1560444098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719301926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":29,"alternative-id":["S0306987719301926"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.05.013","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR\/Cas 9 system for the treatment of dilated cardiomyopathy: A hypothesis related to function of a MAP kinase","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}